Consulting Services
We provide insights for optimum product’s positioning
Prioritis undertakes support for pricing and reimbursement processes for new innovative drugs, extension of indications and reassessment of therapeutic areas. The company approach is highly appreciated by leading Global and European heads of market access and our methodology has become the industry standard, adopted in the majority of requests for proposals.
In-house writing dossier requires extremely specialized skills which our team guarantees thanks to its manpower and resources. Our consultants are able to understand the detailed situations faced by clients’ products kpi’s and to handle the most strategic missions.
Prioritis has proven its ability to compile dossiers for submission to national evaluation agencies, by assisting its clients in their interactions with the authorities at all stages:
- Setting up expert groups and organizing meetings to determine the strategy,
- Writing and compiling the dossier,
- Initiating and organizing further development after submission,
- Obtaining new expert recommendations if needed.
Consulting for market access and value
Prioritis assists pricing and market access teams at every stage of a product’s life:
- Development strategy
- Product lifecycle portfolio strategy
- Value messaging and timing.
Our expert team is able to analyze the efficacy and therapeutic value of each drug, its position in the market, its price expectation, levels of reimbursement and resulting impact on financial forecast.
Complex situations need a unique approach and Prioritis offers the best expert guidance:
- International market access strategic plan
- Outsourced Health Technology Assessment dossier
- Value message development and global value dossier creation
- Economic evidence generation – health economic models
- National reimbursement and pricing applications
- Hospital access.
We provide high standard processes at early stage and experienced support from initial to subsequent evaluation.
Payer advisory board meetings & identification of key stakeholders
Prioritis has developed an extensive network of KOLs and shares a unique relationship with national and local payers across all key markets.
These Ad board meetings enable our clients to:
- Design the right market access strategy
- Define an approach for early value assessment
- Establish a price
- Test the key payer messages
- Elaborate recommendations to support value and price arguments